Poly Medicure Limited(IN:POLYMED)
₹1,679.15-14.05 (-0.83%)
IN:POLYMED
Poly Medicure Limited financials statements
₹1,679.15
At close:-14.05 (-0.83%)
Want to see IN:POLYMED full AI Analyst Report?
Poly Medicure Limited (POLYMED) Ratios
4 Followers
Poly Medicure Limited Ratios
IN:POLYMED's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:POLYMED's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.37 | 5.18 | 2.40 | 2.75 | 3.46 |
| Quick Ratio | 2.62 | 4.41 | 1.77 | 2.04 | 2.71 |
| Cash Ratio | 0.15 | 0.41 | 0.03 | 0.02 | 0.03 |
| Solvency Ratio | 0.57 | 0.98 | 0.82 | 0.70 | 0.69 |
| Operating Cash Flow Ratio | 0.43 | 0.65 | 0.76 | 0.65 | 0.54 |
| Short-Term Operating Cash Flow Coverage | 0.86 | 1.35 | 1.57 | 1.48 | 1.42 |
| Net Current Asset Value | ₹ 11.72B | ₹ 14.90B | ₹ 4.53B | ₹ 4.71B | ₹ 4.94B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.06 | 0.09 | 0.09 | 0.09 |
| Debt-to-Equity Ratio | 0.11 | 0.07 | 0.12 | 0.12 | 0.12 |
| Debt-to-Capital Ratio | 0.10 | 0.06 | 0.11 | 0.11 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.00 | 0.01 | 0.03 |
| Financial Leverage Ratio | 1.26 | 1.15 | 1.26 | 1.27 | 1.27 |
| Debt Service Coverage Ratio | 1.48 | 1.76 | 1.49 | 1.53 | 1.76 |
| Interest Coverage Ratio | 17.87 | 55.40 | 47.36 | 58.69 | 67.38 |
| Debt to Market Cap | 0.03 | 0.01 | 0.01 | 0.02 | 0.01 |
| Interest Debt Per Share | 36.70 | 19.57 | 19.50 | 16.37 | 13.80 |
| Net Debt to EBITDA | 0.47 | 0.06 | 0.45 | 0.53 | 0.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.56% | 66.53% | 64.62% | 63.32% | 62.02% |
| EBIT Margin | 23.77% | 22.26% | 21.54% | 19.08% | 17.29% |
| EBITDA Margin | 29.93% | 27.08% | 26.00% | 24.01% | 22.94% |
| Operating Profit Margin | 17.43% | 46.46% | 44.92% | 43.11% | 41.87% |
| Pretax Profit Margin | 22.80% | 27.10% | 25.02% | 21.30% | 21.15% |
| Net Profit Margin | 17.18% | 20.27% | 18.77% | 16.08% | 15.87% |
| Continuous Operations Profit Margin | 17.10% | 20.27% | 18.77% | 16.08% | 15.87% |
| Net Income Per EBT | 75.36% | 74.82% | 75.02% | 75.49% | 75.04% |
| EBT Per EBIT | 130.81% | 58.32% | 55.70% | 49.40% | 50.51% |
| Return on Assets (ROA) | 8.22% | 10.60% | 13.89% | 11.37% | 10.64% |
| Return on Equity (ROE) | 10.37% | 12.24% | 17.57% | 14.44% | 13.47% |
| Return on Capital Employed (ROCE) | 9.78% | 27.49% | 41.00% | 37.45% | 33.61% |
| Return on Invested Capital (ROIC) | 6.74% | 19.34% | 27.62% | 25.67% | 23.42% |
| Return on Tangible Assets | 9.26% | 10.79% | 14.31% | 11.74% | 11.05% |
| Earnings Yield | 2.67% | 1.59% | 1.71% | 1.96% | 1.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.53 | 4.77 | 5.10 | 4.60 | 4.47 |
| Payables Turnover | 9.09 | 6.47 | 5.09 | 4.43 | 3.94 |
| Inventory Turnover | 2.57 | 1.96 | 2.20 | 1.96 | 2.08 |
| Fixed Asset Turnover | 1.39 | 1.48 | 1.55 | 1.68 | 1.94 |
| Asset Turnover | 0.48 | 0.52 | 0.74 | 0.71 | 0.67 |
| Working Capital Turnover Ratio | 1.29 | 1.64 | 2.74 | 2.08 | 1.69 |
| Cash Conversion Cycle | 205.43 | 206.60 | 165.69 | 183.24 | 164.29 |
| Days of Sales Outstanding | 103.53 | 76.52 | 71.62 | 79.43 | 81.71 |
| Days of Inventory Outstanding | 142.07 | 186.52 | 165.77 | 186.19 | 175.27 |
| Days of Payables Outstanding | 40.17 | 56.45 | 71.69 | 82.38 | 92.69 |
| Operating Cycle | 245.60 | 263.04 | 237.38 | 265.62 | 256.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 24.50 | 24.23 | 27.71 | 19.87 | 12.87 |
| Free Cash Flow Per Share | -5.94 | -9.13 | -1.14 | -5.05 | -3.35 |
| Dividend Paid and CapEx Coverage Ratio | 0.72 | 0.67 | 0.87 | 0.72 | 0.69 |
| Capital Expenditure Coverage Ratio | 0.80 | 0.73 | 0.96 | 0.80 | 0.79 |
| Operating Cash Flow Coverage Ratio | 0.70 | 1.33 | 1.53 | 1.28 | 0.97 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.14 | 0.19 | 0.17 | 0.13 |
| Free Cash Flow Yield | -0.50% | -0.42% | -0.07% | -0.53% | -0.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 37.47 | 63.09 | 58.58 | 51.03 | 62.18 |
| Price-to-Sales (P/S) Ratio | 6.44 | 12.79 | 11.00 | 8.20 | 9.87 |
| Price-to-Book (P/B) Ratio | 3.89 | 7.72 | 10.29 | 7.37 | 8.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -200.59 | -235.73 | -1383.60 | -188.82 | -283.75 |
| Price-to-Operating Cash Flow Ratio | 48.63 | 88.84 | 56.85 | 47.94 | 73.78 |
| Price-to-Earnings Growth (PEG) Ratio | -5.51 | 2.36 | 1.33 | 2.29 | 316.09 |
| Enterprise Value Multiple | 21.98 | 47.30 | 42.75 | 34.70 | 43.57 |
| Enterprise Value | 123.36B | 213.87B | 152.90B | 92.90B | 92.29B |
| EV to EBITDA | 21.98 | 47.30 | 42.75 | 34.70 | 43.57 |
| EV to Sales | 6.58 | 12.81 | 11.11 | 8.33 | 10.00 |
| EV to Free Cash Flow | -205.01 | -236.05 | -1398.43 | -191.75 | -287.45 |
| EV to Operating Cash Flow | 49.70 | 88.96 | 57.46 | 48.68 | 74.74 |
| Tangible Book Value Per Share | 267.45 | 273.11 | 147.54 | 124.08 | 108.07 |
| Shareholders’ Equity Per Share | 306.53 | 278.67 | 153.12 | 129.30 | 113.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Revenue Per Share | 185.06 | 168.26 | 143.30 | 116.14 | 96.21 |
| Net Income Per Share | 31.79 | 34.11 | 26.90 | 18.67 | 15.27 |
| Tax Burden | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
| Interest Burden | 0.96 | 1.22 | 1.16 | 1.12 | 1.22 |
| Research & Development to Revenue | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 |
| SG&A to Revenue | 0.22 | 0.19 | 0.18 | 0.18 | 0.18 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.58 | 0.71 | 1.03 | 0.80 | 0.63 |
Currency in INR

